Beijing ziduhongye technology development co. LTD Report issue

Government Phase 2

Organization Overview

First Clinical Trial
2018
NCT03656120
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing ziduhongye technology development co. LTD

Active Ingredients

Drugs in Phase 2 Trials (1)

Thienorphine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Opioid-Related Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1